News & Stories

Stories to follow

Christina Brandmair

Senior Program Manager Health, Plug and Play

Christina Brandmair

Senior Program Manager Health, Plug and Play

Creasphere Insights – Cardiovascular Disease

Cardiovascular Diseases (CVDs) are the leading cause of death worldwide with an estimated 18M fatalities annually and covering 30% of all fatalities on a global scale. The most common CVDs include coronary heart disease, cerebrovascular disease, and rheumatic heart disease.

Creasphere Insights – Digital Twin

The pursuit of achieving personalized treatment possibilities and optimized health outcomes at scale is one of the key driving forces that will also continue to be explored in 2022. A central framework to foster greater healthcare individualization can be found in the Digital Twin technology.

Creasphere Insights – Brain-Computer-Interfaces

Computers are more indispensable in our daily lives than ever before. They influence how we live in both obvious and non obvious ways. The next obvious development step in human machine interaction is an interface which enables a more frictionless communication.

Raising awareness for World Cancer Day – Feb 4

In light of the World Cancer Day today, we want to take the special opportunity to raise increased awareness and ongoing support to the disease area of cancer and the great patient community involved.

4 healthcare investments at Plug and Play Munich in 2021

In 2021, Plug and Play Munich has invested into four disruptive and promising healthcare startups in the fields of Digital Twin for Medical Device Development, Digital Biomarker Respiratory Diseases, Clinical Workflow Optimization and Digital Biomarker for Eye Health.

Creasphere Insights – Menopause

Menopause is a natural biological process that marks the cessation of the female menstrual cycle, typically occurring for the majority of women in their late 40s and early 50s. In order to lower the severity of symptoms commonly associated with Menopause, digital solutions provide an

Loading new posts...
No more posts

Interested in our program?

Get in touch

    Stay informed!

    Subscribe to our newsletter